← back to search

Dongwei Xu

Mudanjiang Medical University · CN
Area of research
Epidemiology · Surgery
Research interest
Research interests include Autophagy in Disease and Therapy, Organ Transplantation Techniques and Outcomes, Drug-Induced Hepatotoxicity and Protection, and interferon and immune responses.
h-index
22
citations
1,548
works
70
NIH funding
primary concept
Medicine
email

Recent publications

The Foxo1-YAP-Notch1 axis reprograms STING-mediated innate immunity in NASH progression
Experimental & Molecular Medicine 2024cited by 24position: firstdoi
The macrophage STING-YAP axis controls hepatic steatosis by promoting the autophagic degradation of lipid droplets
Hepatology 2023cited by 45position: middledoi
Macrophage RIPK3 triggers inflammation and cell death via the XBP1–Foxo1 axis in liver ischaemia–reperfusion injury
JHEP Reports 2023cited by 22position: middledoi
Novel role of macrophage TXNIP-mediated CYLD–NRF2–OASL1 axis in stress-induced liver inflammation and cell death
JHEP Reports 2022cited by 63position: middledoi
The cGAS-STING Pathway: Novel Perspectives in Liver Diseases
Frontiers in Immunology 2021cited by 82position: firstdoi
CD47‐Mediated Hedgehog/SMO/GLI1 Signaling Promotes Mesenchymal Stem Cell Immunomodulation in Mouse Liver Inflammation
Hepatology 2021cited by 61position: middledoi
Functional crosstalk between myeloid Foxo1–β-catenin axis and Hedgehog/Gli1 signaling in oxidative stress response
Cell Death and Differentiation 2020cited by 90position: middledoi
The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches
Frontiers in Pharmacology 2019cited by 256position: firstdoi
Jagged1-mediated myeloid Notch1 signaling activates HSF1/Snail and controls NLRP3 inflammasome activation in liver inflammatory injury
Cellular and Molecular Immunology 2019cited by 105position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bibo Ke · UCLA Medical Center8 papers (2019–2024)Qiang Xia · Zunyi Medical University7 papers (2019–2024)Mingwei Sheng · Tianjin First Center Hospital6 papers (2019–2024)Douglas G. Farmer · UCLA Medical Center6 papers (2020–2024)Longfeng Jiang · Infectious Disease Consultants5 papers (2020–2024)Yizhu Tian · Zhejiang International Studies University5 papers (2020–2024)Yuanbang Lin · Tianjin Medical University General Hospital5 papers (2020–2024)Yongqiang Zhan · University of California, Los Angeles4 papers (2020–2024)Changyong Li · Tianjin University4 papers (2019–2024)Xiao Wang · 81th Hospital of PLA3 papers (2023–2024)Tao Yang · Guiyang College of Traditional Chinese Medicine3 papers (2023–2024)Jerzy W. Kupiec‐Weglinski · Riverside Transplantation Institute3 papers (2019–2021)Michael Ke · University of California, Los Angeles3 papers (2022–2024)Xiaoye Qu · Renji Hospital2 papers (2022–2023)Ana J. Coito · University of California, Los Angeles2 papers (2019–2020)Yuting Jin · Nanjing University of Chinese Medicine2 papers (2019–2024)X. B. Qu · MEI Technologies (United States)2 papers (2023–2024)Ronald W. Busuttil · University of California, Los Angeles2 papers (2019–2020)Xiaoni Kong · Shanghai University1 papers (2019–2019)Jun Li · Ministry of Education of the People's Republic of China1 papers (2023–2023)